A Deep Dive With MedNet Solutions CEO On The $16m Round


rrobertson-websmallMinnetonka based MedNet Solutions closed on a $16m investment round last week to fuel the growth of their clinical trial software.

We connected with cofounder and CEO Rob Robertson for a deep dive on his firm and the deal:

What is your background as it relates to MedNet Solutions?

I am one of the original four founders of the company, which dates as far back as 2001.   This was the early stages of the eclinical and digitization of clinical trials.

Are the other three individuals still with the company?

Yes, two of them are – Brian Sweeney and Al Sherwood.

How do you describe your technology and solution in the market?

If you’re a medical device or pharmaceutical company, you have to conduct a series of FDA clinical trials to get your drug or device to the market.  Our iMedNet eClinical offering allows the trial to be conducted in an efficient, reliable and cost-effective manner.